| Literature DB >> 35281605 |
Yahya S Alqahtani1, Mater H Mahnashi1, Bandar A Alyami1, Ali O Alqarni1, Mohammed A Huneif2, Mohammed H Nahari3, Anser Ali4, Qamar Javed4, Hina Ilyas4, Muhammad Rafiq5.
Abstract
Tyrosinase and α-glucosidase enzymes are known as promising target candidates for inhibitors to control unwanted pigmentation and type II diabetics mellitus. Therefore, twenty extracts as enzyme inhibitors were prepared from edible spices: nutmeg, mace, star anise, fenugreek, and coriander aiming to explore their antioxidant, antibrowning, and antidiabetic potential. Results confirmed that all extracts showed potent antioxidant activity ranging from IC50 = 0.14 ± 0.03 to 3.69 ± 0.37 μg/mL. In addition, all extracts exhibited excellent antityrosinase (IC50 = 1.16 ± 0.06 to 71.32 ± 4.63 μg/mL) and anti-α-glucosidase (IC504.76 ± 0.71 to 42.57 ± 2.13 μg/mL) activities outperforming the corresponding standards, hydroquinone, and acarbose, respectively. Among all extracts, star anise ethyl acetate (Star anise ETAC) was found most potent inhibitor for both tyrosinase and α-glucosidase enzymes and was further studied to explore the mechanism of enzyme inhibition. Kinetic analysis revealed its irreversible but mixed-type tyrosinase inhibition with preferentially competitive mode of action. However, it binds reversibly with α-glucosidase through competitive mode of action. Further, star anise ETAC extract showed concentration dependent and posttreatment time-dependent antibrowning effect on potato slices and antidiabetic effect on diabetic rabbits in vivo proposing it promising candidate for tyrosinase-rooted antibrowning and α-glucosidase-associated diabetes management for future studies.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35281605 PMCID: PMC8916850 DOI: 10.1155/2022/9983124
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Antioxidant activity of prepared extracts.
| DDPH assay inhibition IC50 ± SEM ( | |||||
|---|---|---|---|---|---|
| Extract | MeOH | ETAC | n-Hex | CHLO | |
| Nutmeg | 3.39 ± 0.67 | 1.65 ± 0.36 | 1.38 ± 0.27 | 1.19 ± 0.09 | |
| Mace | 1.33 ± 0.16 | 0.64 ± 0.09 | 0.26 ± 0.1 | 0.59 ± 0.07 | |
| Star anise | 2.67 ± 0.65 | 0.68 ± 0.13 | 3.16 ± 0.16 | 1.67 ± 0.17 | |
| Fenugreek | 1.83 ± 0.18 | 0.14 ± 0.03 | 0.22 ± 0.02 | 0.41 ± 0.04 | |
| Coriander | 0.7 ± 0.11 | 0.31 ± 0.06 | 3.69 ± 0.37 | 0.79 ± 0.12 | |
| Ascorbic acid | 1.16 ± 0.06 | ||||
Tyrosinase and α-glucosidase inhibitory activity of prepared extracts.
| Extract | MeOH | ETAC | n-Hex | CHLO |
|---|---|---|---|---|
| Tyrosinase inhibition IC50 ± SEM ( | ||||
| Nutmeg | 24.66 ± 2.46 | 6.43 ± 0.96 | 1.91 ± 0.1 | 2.74 ± 0.1 |
| Mace | 5.91 ± 0.45 | 2.82 ± 0.18 | 2.39 ± 0.63 | 7.99 ± 0.6 |
| Star anise | 9.86 ± 0.84 | 1.16 ± 0.06 | 3.9 ± 0.58 | 2.09 ± 0.14 |
| Fenugreek | 31.23 ± 1.56 | 2.73 ± 0.27 | 19.12 ± 1 | 34.86 ± 1.74 |
| Coriander | 71.32 ± 4.63 | 10.5 ± 0.53 | 3.02 ± 0.3 | 9.65 ± 0.63 |
| Hydroquinone | 131.34 ± 9.82 (standard for tyrosinase) | |||
|
| ||||
| Nutmeg | 40.65 ± 4.05 | 6.72 ± 0.67 | 23.37 ± 1.17 | 5.5 ± 0.55 |
| Mace | 22.31 ± 2.22 | 20.18 ± 2.01 | 16.78 ± 2.34 | 23.32 ± 2.21 |
| Star anise | 42.57 ± 2.13 | 4.76 ± 0.71 | 16.52 ± 1.65 | 9.21 ± 1.82 |
| Fenugreek | 17.76 ± 1.33 | 6.05 ± 0.67 | 15.82 ± 2.36 | 17.86 ± 2.22 |
| Coriander | 19.13 ± 1 | 25.82 ± 1.29 | 30.52 ± 1.92 | 42.57 ± 2.13 |
| Acarbose | 201.34 ± 20.07 (standard for | |||
Figure 1Mechanism of tyrosinase inhibition. (a) Lineweaver-Burk plot (LBP) for inhibition of tyrosinase enzyme in the presence of Star anise ETAC extract. The extract concentrations 0-13 μg/mL; however, L-DOPA concentrations ranging from 0.125 to 2 mM were used. (b) The insets represent the plot of the slope from LBP versus extract. (c) The secondary replot of the LBP, 1/V (y-intercept) of versus various concentrations of extract. (d) The Dixon plot of the reciprocal of the initial velocities versus various concentrations of extract as inhibitor. (e) Relationship between the catalytic activity of L-DOPA and various concentrations of extract.
Inhibitory behaviour of most potent extract on tyrosinase and α-glucosidase enzymes.
| Extract | Enzyme |
|
| Type of inhibitor | Catalytic activity |
|---|---|---|---|---|---|
| Star anise ETAC | Tyrosinase | 8.2 | 37 | Mix type | Irreversible |
|
| 34 | 34 | Competitive | Reversible |
Figure 2Antibrowning effect of star anise ETAC extract on potato slices. Cont (-): slices without any treatment; Cont: water; star anise ETAC extract = 1 and 1.5 mg/mL.
Figure 3Mechanism of α-glucosidase inhibition. (a) Lineweaver-Burk plot (LBP) for the inhibition of α-glucosidase in the presence of Star anise ETAC extract. The extract concentrations 0-45 μg/mL; however, pNPG concentrations (0.125 to 1 mM) were used. (b) The insets represent the plot of the slope from LBP versus inhibitor. (c) The secondary replot of the LBP, 1/V (y-intercept) of versus various concentrations of inhibitor. (d) The Dixon plot of the reciprocal of the initial velocities versus various concentrations of extract as inhibitor. (e) Relationship between the catalytic activity of pNPG and various concentrations of extract.
Figure 4Diabetes analysis in rabbits. (a) Body weight of rabbits. (b) Measurement of blood glucose level. Experiments were performed thrice, and significance between alloxan (alxn) and alxn+Star anise ETAC was determined by Student's t-test as x < 0.0001, y < 0.0000001, and z < 0.000000001.
Phytochemical analysis of star anise ETAC extract.
| Phytochemicals tested | Star anise ETAC | Phytochemicals tested | Star anise ETAC |
|---|---|---|---|
| Flavonoids | + | Glycosides | + |
| Saponins | + | Cardiac glycosides | + |
| Alkaloids | + | Terpenoids | + |
| Tannins | + | Phenols | + |
| Coumarins | + | Quinones | + |
| Anthocyanin and betacyanin | + | Steroids | + |
+: present.